NEW YORK – HTG Molecular on Tuesday reported a nearly 55 percent year-over-year drop in preliminary revenues for 2020.
The Tucson, Arizona-based firm said that preliminary revenues for 2020 are expected to be $8.5 million compared with $19.2 million in 2019. On average, analysts are expecting HTG to report 2020 revenues of about $8.0 million.
HTG also said that it expects to have cash, cash equivalents, and short-term marketable securities of about $28.7 million.